C

Medexus Pharmaceuticals Inc. MEDXF

OTC PK
Recommendation
Dividend Power Score
Day's Range
$3.80$3.88
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income 49.45% 120.34% -3,443.75% 125.40% -161.05%
Total Depreciation and Amortization 0.12% -1.75% 1.32% -0.16% 0.08%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -73.86% -66.55% 116.35% -2.25% 281.36%
Change in Net Operating Assets 139.85% -691.42% -79.10% 1,426.55% -150.00%
Cash from Operations 843.33% -119.20% -51.64% 134.67% -14.85%
Capital Expenditure -36.36% -633.33% 84.21% -171.43% 94.40%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -230.93% 7.32% -17.44% 75.30% -346.61%
Divestitures -- -- -- -- --
Other Investing Activities -- 73.33% -50.00% -- --
Cash from Investing 39.31% 69.11% -47.09% -227.85% 29.30%
Total Debt Issued -- 226,900.00% -100.01% -- --
Total Debt Repaid 90.33% 81.50% 85.47% -1,761.97% 92.56%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock 64.57% -30.88% -208.27% -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 30.31% -10.26% 26.36% -16.74% 40.19%
Cash from Financing -143.65% 148.53% -232.81% 296.50% 90.18%
Foreign Exchange rate Adjustments -25.00% 85.88% -280.85% 238.24% -147.22%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 355.22% 86.05% -251.09% 11,316.33% 100.33%